PRLD:NASDAQ, Prelude Therapeutics Incorporated

PRLD stock overview

Prelude Therapeutics Incorporated (PRLD:NASDAQ) closed at $3.45 on November 13, 2026, down 1.99% on the day. The stock trades 49.5% below its 52-week high of $6.83 and 166.4% above its 52-week low of $1.30. Over the past year, it gained 127.0%. Prelude Therapeutics Incorporated is part of the Health Care sector.

Key figures

Price: $3.45
Day change: -1.99%
Volume: 262,091
Average volume: 474,007
Market cap: 275M+
52-week range: $1.30 – $6.83
50-day average: $4.04
200-day average: $4.09

Price action over the past year

In 252 trading sessions since November 13, 2025, PRLD closed higher on 129 days (51%). Its best day was April 15, 2026 (+25.45%) and its worst was April 16, 2026 (-19.75%). The stock moved 10% or more in a single session 35 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

Nov 13, 2026: Down 38.7% over 90 days, from $5.63 (Dips & Crashes scanner)
Nov 13, 2026: Hit a new 2-Week Low of $3.45 (New Highs/Lows scanner)

PRLD news

Nov 5, 2026: Earnings Preview: Merck KGaA (MKKGY) Q3 Earnings Expected to Decline
Nov 5, 2026: Xeris Biopharma (XERS) Surpasses Q3 Earnings and Revenue Estimates
Nov 4, 2026: Prelude Therapeutics Incorporated (PRLD) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Oct 27, 2026: Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Strength?
Oct 23, 2026: Prelude Therapeutics Spotlights JAK2, KAT6A Programs and Potential $100M Incyte Option
Oct 16, 2026: Prelude Therapeutics to Participate in the Chardan Healthcare Conference
Oct 16, 2026: Down 27.4% in 4 Weeks, Here's Why Prelude Therapeutics (PRLD) Looks Ripe for a Turnaround
Oct 15, 2026: Eli Lilly (LLY) Reported One Year Steroid Free Control In Difficult IBD

About Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.

Similar stocks

Find more stocks like PRLD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.